Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03200847
Title Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

melanoma

Therapies

Pembrolizumab + Tretinoin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.